Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Multi-Center Safety Study Examining the Use of the O'Neil Long Acting Naltrexone Implant (OLANI) in Opioid Dependent Persons Receiving Repeat Dosing

NCT05382091 is registered in ClinicalTrials.gov with Go Medical Industries Pty Ltd as lead sponsor.

NCT NCT05382091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05382091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Multi-Center Safety Study Examining the Use of the O'Neil Long Acting Naltrexone Implant (OLANI) in Opioid Dependent Persons Receiving Repeat Dosing
Lead sponsor
Go Medical Industries Pty Ltd
Phase
Phase 2
Overall status
Not yet recruiting
Start date
January 1, 2027
Completion date
July 1, 2030
Enrollment
250 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder